<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Russian Journal of Biological Physics and Chemisrty</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Russian Journal of Biological Physics and Chemisrty</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>АКТУАЛЬНЫЕ ВОПРОСЫ БИОЛОГИЧЕСКОЙ ФИЗИКИ И ХИМИИ</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2499-9962</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">54350</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Общая биофизика</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>General biophysics</subject>
    </subj-group>
    <subj-group>
     <subject>Общая биофизика</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">CHANGE IN THE LEVEL OF ROS IN HELA KYOTO CELLS AT DIFFERENT STAGES OF CISPLATIN-INDUCED CELL DEATH</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>ИЗМЕНЕНИЕ УРОВНЯ АФК В КЛЕТКАХ HELA KYOTO НА РАЗНЫХ СТАДИЯХ ЦИСПЛАТИН-ИНДУЦИРОВАННОЙ КЛЕТОЧНОЙ ГИБЕЛИ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Щукина</surname>
       <given-names>К М</given-names>
      </name>
      <name xml:lang="en">
       <surname>Shchukina</surname>
       <given-names>K M</given-names>
      </name>
     </name-alternatives>
     <email>ksushaschukina1995@yandex.ru</email>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Неруш</surname>
       <given-names>А С</given-names>
      </name>
      <name xml:lang="en">
       <surname>Nerush</surname>
       <given-names>A S</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-2"/>
    </contrib>
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Орлова</surname>
       <given-names>А Г</given-names>
      </name>
      <name xml:lang="en">
       <surname>Orlova</surname>
       <given-names>A G</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-3"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Национальный исследовательский Нижегородский государственный университет им. Н.И. Лобачевского</institution>
     <country>ru</country>
    </aff>
    <aff>
     <institution xml:lang="en">Lobachevsky State University of Nizhny Novgorod</institution>
     <country>ru</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-2">
    <aff>
     <institution xml:lang="ru">Федеральный исследовательский центр Институт прикладной физики РАН</institution>
     <country>ru</country>
    </aff>
    <aff>
     <institution xml:lang="en">Institute of Applied Physics RAS</institution>
     <country>ru</country>
    </aff>
   </aff-alternatives>
   <aff-alternatives id="aff-3">
    <aff>
     <institution xml:lang="ru">Федеральный исследовательский центр Институт прикладной физики РАН</institution>
     <country>ru</country>
    </aff>
    <aff>
     <institution xml:lang="en">Institute of Applied Physics RAS</institution>
     <country>ru</country>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2018-12-25T20:22:29+03:00">
    <day>25</day>
    <month>12</month>
    <year>2018</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2018-12-25T20:22:29+03:00">
    <day>25</day>
    <month>12</month>
    <year>2018</year>
   </pub-date>
   <volume>3</volume>
   <issue>4</issue>
   <fpage>699</fpage>
   <lpage>705</lpage>
   <history>
    <date date-type="received" iso-8601-date="2018-12-20T20:22:29+03:00">
     <day>20</day>
     <month>12</month>
     <year>2018</year>
    </date>
    <date date-type="accepted" iso-8601-date="2018-12-20T20:22:29+03:00">
     <day>20</day>
     <month>12</month>
     <year>2018</year>
    </date>
   </history>
   <self-uri xlink:href="https://rusjbpc.ru/en/nauka/article/54350/view">https://rusjbpc.ru/en/nauka/article/54350/view</self-uri>
   <abstract xml:lang="ru">
    <p>Цисплатин - химиотерапевтический препарат, успешно применяемый в лечении широкого спектра опухолей. Данный препарат может вызвать митохондриальную дисфункцию и повышенное производство активных форм кислорода (АФК), что приводит к повреждению мембраны, ДНК и других важных элементов клетки. Целью работы было исследование изменений уровня АФК на разных стадиях клеточной гибели, вызванной цисплатином. В работе использовалась линия HeLa Kyoto, флуоресцентный краситель DCFH-DA, маркер апоптоза ФЭ-Аннексин V и витальный краситель 7-актиноаминомицин D. С использованием метода проточной цитофлуориметрии было показано, что большинство жизнеспособных клеток после обработки препаратом интенсивно окрашиваются DCFH-DA, что свидетельствует об активно идущих в них окислительных процессах и высоком уровне АФК. На стадии раннего апоптоза количество АФК уменьшается по сравнению с необработанным препаратом клетками.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Cisplatin is a chemotherapeutic drug, successfully used in the treatment of a wide range of tumors. This drug can cause mitochondrial dysfunction and increased production of reactive oxygen spices (ROS), which leads to the damage of membrane, DNA and other important cell elements. The aim of the study was to investigate the changes in the level of ROS at different stages of cell death caused by cisplatin. We used the HeLa Kyoto cell line, the fluorescent dye DCFH-DA, the marker of apoptosis PE-Annexin V, and the vital dye 7-actinaminomycin D. Using flow cytometry, it was shown that after treatment most of viable cells are intensely stained with DCFH-DA, which indicates active oxidation processes and high level of ROS. At the stage of early apoptosis, the amount of ROS decreases as compared to the untreated cells.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>цисплатин</kwd>
    <kwd>активные формы кислорода</kwd>
    <kwd>апоптоз</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>cisplatin</kwd>
    <kwd>reactive oxygen spices</kwd>
    <kwd>apoptosis</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 1991, vol. 51, pp. 794-798.</mixed-citation>
     <mixed-citation xml:lang="en">Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res., 1991, vol. 51, pp. 794-798.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Toyokuni S., Okamoto K., Yodoi J., Hiai H. Pers is tent oxidative s tres s in cancer. FEBS Lett., 1995, vol. 358, pp. 1-3.</mixed-citation>
     <mixed-citation xml:lang="en">Toyokuni S., Okamoto K., Yodoi J., Hiai H. Pers is tent oxidative s tres s in cancer. FEBS Lett., 1995, vol. 358, pp. 1-3.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Liou G.-Y., Storz P. Reactive oxygen species in cancer. Free Radic Res., 2010, vol. 44, no. 5, pp. 479-496.</mixed-citation>
     <mixed-citation xml:lang="en">Liou G.-Y., Storz P. Reactive oxygen species in cancer. Free Radic Res., 2010, vol. 44, no. 5, pp. 479-496.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov., 2009, vol. 8, no. 7, pp. 579-591.</mixed-citation>
     <mixed-citation xml:lang="en">Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov., 2009, vol. 8, no. 7, pp. 579-591.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Conklin K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, 2004, vol. 3, no. 4, pp. 294-300.</mixed-citation>
     <mixed-citation xml:lang="en">Conklin K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, 2004, vol. 3, no. 4, pp. 294-300.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Florea A.-M., Bus selberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers, 2011, vol. 3, no. 1, pp. 1351-1371.</mixed-citation>
     <mixed-citation xml:lang="en">Florea A.-M., Bus selberg D. Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers, 2011, vol. 3, no. 1, pp. 1351-1371.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Loskotova H., Brabec V. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. Eur. J. Biochem., 1999, vol. 266, pp. 392-402.</mixed-citation>
     <mixed-citation xml:lang="en">Loskotova H., Brabec V. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. Eur. J. Biochem., 1999, vol. 266, pp. 392-402.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Choi Y.-M., Kim H.-K., Shim W., Anwar M.A., Kwon J.-W., Kwon H.-K., Kim H.J., Jeong H., Kim H.M., Hwang D., Kim H.S., Choi S. Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation. PLoS One, 2015, vol. 10, no. 8, p. 21.</mixed-citation>
     <mixed-citation xml:lang="en">Choi Y.-M., Kim H.-K., Shim W., Anwar M.A., Kwon J.-W., Kwon H.-K., Kim H.J., Jeong H., Kim H.M., Hwang D., Kim H.S., Choi S. Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation. PLoS One, 2015, vol. 10, no. 8, p. 21.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kim H.-J., Lee J-H., Kim S.-J., Oh G.S., Moon H.-D., Kwon K.-B., Park C., Park B.H., Lee H.-K, Chung S.-Y., Park R., So H.-S. Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity. JNeurosci, 2010, vol. 30, no. 11, рр. 3933-3946.</mixed-citation>
     <mixed-citation xml:lang="en">Kim H.-J., Lee J-H., Kim S.-J., Oh G.S., Moon H.-D., Kwon K.-B., Park C., Park B.H., Lee H.-K, Chung S.-Y., Park R., So H.-S. Roles of NADPH Oxidases in Cisplatin-Induced Reactive Oxygen Species Generation and Ototoxicity. JNeurosci, 2010, vol. 30, no. 11, rr. 3933-3946.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Guo J, Xu B., Han Q., Zhou H., Xia Y., Gong C., Dai X., Li Z., Wu G. Ferroptosis: A Novel Anti-tumor Action for Cisplatin. Cancer Res. Treat., 2018, vol. 50, no. 2, pp. 445-460.</mixed-citation>
     <mixed-citation xml:lang="en">Guo J, Xu B., Han Q., Zhou H., Xia Y., Gong C., Dai X., Li Z., Wu G. Ferroptosis: A Novel Anti-tumor Action for Cisplatin. Cancer Res. Treat., 2018, vol. 50, no. 2, pp. 445-460.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Marullo R., Werner E., Degtyareva N., Moore B., Altavilla G., Ramalingam S., Doetsch P. Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions. PLoS One, 2013, vol. 8, no. 11, p. 15.</mixed-citation>
     <mixed-citation xml:lang="en">Marullo R., Werner E., Degtyareva N., Moore B., Altavilla G., Ramalingam S., Doetsch P. Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions. PLoS One, 2013, vol. 8, no. 11, p. 15.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pavelescu L.A. On reactive oxygen species measurement in living systems? J. Med. Life, 2015, vol. 8, pp. 38-42.</mixed-citation>
     <mixed-citation xml:lang="en">Pavelescu L.A. On reactive oxygen species measurement in living systems? J. Med. Life, 2015, vol. 8, pp. 38-42.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Belova А.S., Orlova A.G., Balalaeva I.V., Antonova N.O., Maslennikova A.V., Mishina N.M., Zagaynova E.V. Hydrogen peroxide detection in viable and apoptotic tumor cells under action of cisplatin and bleomycin. Photonics &amp; Lasers in Medicine, 2016, vol. 5, no. 2, pp. 113-121.</mixed-citation>
     <mixed-citation xml:lang="en">Belova A.S., Orlova A.G., Balalaeva I.V., Antonova N.O., Maslennikova A.V., Mishina N.M., Zagaynova E.V. Hydrogen peroxide detection in viable and apoptotic tumor cells under action of cisplatin and bleomycin. Photonics &amp; Lasers in Medicine, 2016, vol. 5, no. 2, pp. 113-121.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Louis K.S., Siegel A.C. Cell viability analysis using trypan blue: manual and automated methods. Methods Mol. Biol., 2011, vol. 740, pp. 7-12.</mixed-citation>
     <mixed-citation xml:lang="en">Louis K.S., Siegel A.C. Cell viability analysis using trypan blue: manual and automated methods. Methods Mol. Biol., 2011, vol. 740, pp. 7-12.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Burow S., Valet G. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2.7-dichlorofluorescein (DCF). Eur. J. Cell. Biol., 1987, vol. 43, pp. 128-133.</mixed-citation>
     <mixed-citation xml:lang="en">Burow S., Valet G. Flow-cytometric characterization of stimulation, free radical formation, peroxidase activity and phagocytosis of human granulocytes with 2.7-dichlorofluorescein (DCF). Eur. J. Cell. Biol., 1987, vol. 43, pp. 128-133.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2, 7-dichlorofl uorescin. J. Leukoc. Biol., 1990, vol. 47, pp. 440-448.</mixed-citation>
     <mixed-citation xml:lang="en">Rothe G., Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2, 7-dichlorofl uorescin. J. Leukoc. Biol., 1990, vol. 47, pp. 440-448.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Белова А.С., Орлова А.Г., Брилкина А.А., Масленникова А.В. Чувствительность клеток линии Hela Kyoto трансфицированных сенсором HyPer2 к действию цисплатина. СТМ, 2014, т. 6, № 4, c. 7-13. [Belova А.S., Orlova A.G., Brilkina А.А., Maslennikova A.V., The sensitivity of Hela Kyoto cell line transfected with sensor HyPer2 to cisplatin. STM, 2014, vol. 6, no. 4, pp. 7-13. (In Russ.)]</mixed-citation>
     <mixed-citation xml:lang="en">Belova A.S., Orlova A.G., Brilkina A.A., Maslennikova A.V. Chuvstvitel'nost' kletok linii Hela Kyoto transficirovannyh sensorom HyPer2 k deystviyu cisplatina. STM, 2014, t. 6, № 4, c. 7-13. [Belova A.S., Orlova A.G., Brilkina A.A., Maslennikova A.V., The sensitivity of Hela Kyoto cell line transfected with sensor HyPer2 to cisplatin. STM, 2014, vol. 6, no. 4, pp. 7-13. (In Russ.)]</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide, 1997, vol. 1, pp. 145-157.</mixed-citation>
     <mixed-citation xml:lang="en">Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide, 1997, vol. 1, pp. 145-157.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med., 1999, vol. 27, pp. 612-616.</mixed-citation>
     <mixed-citation xml:lang="en">Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med., 1999, vol. 27, pp. 612-616.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Franskevych D.V., Grynyuk I.I., Prylutska S.V., Matyshevska O.P. Modulation of cisplatin-induced reactive oxygen species production by fullerene C(60) in normal and transformed lymphoid cells. Ukr. Biochem. J., 2016, vol. 88, pp. 44-50.</mixed-citation>
     <mixed-citation xml:lang="en">Franskevych D.V., Grynyuk I.I., Prylutska S.V., Matyshevska O.P. Modulation of cisplatin-induced reactive oxygen species production by fullerene C(60) in normal and transformed lymphoid cells. Ukr. Biochem. J., 2016, vol. 88, pp. 44-50.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Itoh T., Terazawa R., Kojima K., Nakane K., Deguchi T., Ando M., Tsukamasa Y., Ito M., Nozawa Y. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic. Res., 2011, vol. 45, no. 9, pp. 1033-1039.</mixed-citation>
     <mixed-citation xml:lang="en">Itoh T., Terazawa R., Kojima K., Nakane K., Deguchi T., Ando M., Tsukamasa Y., Ito M., Nozawa Y. Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic. Res., 2011, vol. 45, no. 9, pp. 1033-1039.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Kalyanaraman B., Darley-Usmar V., Davies K.J.A., Dennery P.A, Forman H.J., Grisham M.B., Mann G.E., Moore K., Jackson Roberts II L., Ischiropoulose H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med., 2012, vol. 52, no. 1, p. 6.</mixed-citation>
     <mixed-citation xml:lang="en">Kalyanaraman B., Darley-Usmar V., Davies K.J.A., Dennery P.A, Forman H.J., Grisham M.B., Mann G.E., Moore K., Jackson Roberts II L., Ischiropoulose H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic. Biol. Med., 2012, vol. 52, no. 1, p. 6.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Karlsson M., Kurz T., Brunk U.T., Nilsson. S.E., Frennesson C.I. What does the commonly used DCF test for oxidative stress really show? Biochem. J., 2010, vol. 428, pp. 183-190.</mixed-citation>
     <mixed-citation xml:lang="en">Karlsson M., Kurz T., Brunk U.T., Nilsson. S.E., Frennesson C.I. What does the commonly used DCF test for oxidative stress really show? Biochem. J., 2010, vol. 428, pp. 183-190.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Qian S.Y., Buettner G.R. Iron and dioxygen chemistry is an important route to initiation of biological and free radical oxidations: an electron paramagnetic resonance spin trapping study. Free Radic. Biol. Med., 1999, vol. 26, pp. 1447-1456.</mixed-citation>
     <mixed-citation xml:lang="en">Qian S.Y., Buettner G.R. Iron and dioxygen chemistry is an important route to initiation of biological and free radical oxidations: an electron paramagnetic resonance spin trapping study. Free Radic. Biol. Med., 1999, vol. 26, pp. 1447-1456.</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
